School of Medicine
Showing 11-20 of 48 Results
-
Simon Conti
Clinical Associate Professor, Urology
BioI am a founding member of the Stanford Urolithiasis Project, where we have studied population health datasets to examine surgical outcomes and environmental risk factors in urinary stone disease. Our current focus includes socioeconomic and ethnic disparities in kidney stone disease, water quality and stone disease, pregnancy in kidney stone disease and geographical variations in kidney stones incidence and metabolic kidney stone work up.
-
Amy D. Dobberfuhl, MD, MS
Assistant Professor of Urology
Current Research and Scholarly InterestsDr. Dobberfuhl's current clinical practice includes: Pelvic Reconstruction, Neurourology, and Voiding Dysfunction. A large proportion of Dr. Dobberfuhl's Voiding Dysfunction practice includes Bladder Pain Syndrome (BPS) and Pelvic Floor Dysfunction (PFD).
-
Ekene Enemchukwu
Assistant Professor of Urology and, by courtesy, of Obstetrics and Gynecology (Urogynecology)
Current Research and Scholarly InterestsRefractory overactive bladder in elderly and frail patient populations, detrusor underactivity, quality of life, patient outcomes, quality improvement, patient satisfaction, and shared decision making
-
Alice C. Fan
Assistant Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
-
Richard E. Fan
Clinical Assistant Professor, Urology
BioRichard E. Fan, Ph.D., is an engineer embedded in the Department of Urology in the Stanford School of Medicine.
Dr. Fan’s research relates to the development of clinically driven biomedical instrumentation and medical devices. He is interested in translational application of emerging technologies in the medical and surgical spaces, as well as the development of platforms to explore clinical and pre-clinical evaluation. His primary work is currently focused on image guided detection and treatment of prostate cancer, including MR-US fusion, focal therapies, embedded systems and robotics. -
Wendy Fantl
Associate Professor (Research) of Urology
On Leave from 08/13/2022 To 08/12/2024Current Research and Scholarly InterestsDr Fantl’s lab studies two key questions with unmet clinical need related to drug resistance and immunotherapy focusing on ovarian and kidney cancers. The lab applies multi-parametric single-cell proteomic technologies (mass cytometry aka Cytometry by Time-Of-Flight (CyTOF) and multiplex imaging (CO-Detection by indEXing (CODEX)) combined with specialized computational approaches.
